OBX

Obsidian Therapeutics, Inc. - Common Stock (OBX)

About Obsidian Therapeutics, Inc. - Common Stock (OBX)

Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.

Details

Daily high

$20.20

Daily low

$16.31

Price at open

$19.26

52 Week High

$49.97

52 Week Low

$14.57

Market cap

20.3M

Dividend yield

Volume

112,274

Avg. volume

49,202

P/E ratio

.04

Obsidian Therapeutics, Inc. - Common Stock News